from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0580c/-

LFCtreatmentdescriptionclass of inhibitor

-1.015

Amikacinug/mL Amikacintranslation

-1.330

Cap5-10ug/mL Capreomycintranslation

-1.474

Rox10-50 ug/mL Roxithromycintranslation

-0.802

SM2-5 ug/mL Streptomycintranslation

-1.666

Tet5-10 ug/mL Tetracyclinetranslation

0.263

Rif0.2-5ug/mL Rifampicintranscription

-0.750

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.247

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.801

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.103

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.645

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.616

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.123

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.026

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.114

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.045

Nigericin50 uM Nigericinrespiration

1.577

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.295

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.362

menadione6-10 ug/mL Menadionerespiration

0.516

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.467

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.066

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.802

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.912

NRP_1Non-replicating persistence stage 1dosRassociated

-0.034

Amp0.2mg/mL AmpicillincellWall

0.229

Cephalexin20-100 ug/mL CephalexincellWall

-0.906

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.330

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.184

EMB10-20 ug/mL EthambutolcellWall

0.466

Eta12-40 ug/mL EthionamidecellWall

0.305

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.370

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.350

BZA0.12 mg/mL BenzamidearomaticAmides

-0.459

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.272

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.212

H2O24 mM hydrogen peroxideDNAdamaging

-0.118

Levo10 ug/mL LevofloxacinDNAdamaging

-0.234

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.119

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.738

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.240

Antimycin12.5-50 ug/mL Antimycin A?

-0.797

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.222

PA_110-50 ug/mL Antitubercular compound PA-1?

0.442

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.044

PA8240.2-2 ug/mL PA-824?

-0.384

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.142

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.049

Verapamil50 uM Verapamil?

-0.014

mercaptoethanol2 mM 2-Mercaptoethanol?

1.095

methoxatin10-20 ug/mL Methoxatin?